105 related articles for article (PubMed ID: 10208425)
1. Suppression of src-induced transformed phenotype by expression of tropomyosin-1.
Prasad GL; Masuelli L; Raj MH; Harindranath N
Oncogene; 1999 Mar; 18(11):2027-31. PubMed ID: 10208425
[TBL] [Abstract][Full Text] [Related]
2. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
[TBL] [Abstract][Full Text] [Related]
3. Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences.
Braverman RH; Cooper HL; Lee HS; Prasad GL
Oncogene; 1996 Aug; 13(3):537-45. PubMed ID: 8760295
[TBL] [Abstract][Full Text] [Related]
4. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
Lin X; Gelman IH
Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
[TBL] [Abstract][Full Text] [Related]
5. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors.
Raval GN; Bharadwaj S; Levine EA; Willingham MC; Geary RL; Kute T; Prasad GL
Oncogene; 2003 Sep; 22(40):6194-203. PubMed ID: 13679858
[TBL] [Abstract][Full Text] [Related]
6. Suppression of neoplastic transformation and regulation of cytoskeleton by tropomyosins.
Shah V; Braverman R; Prasad GL
Somat Cell Mol Genet; 1998 Sep; 24(5):273-80. PubMed ID: 10696235
[TBL] [Abstract][Full Text] [Related]
7. Role of a signal transduction pathway which controls disassembly of microfilament bundles and suppression of high-molecular-weight tropomyosin expression in oncogenic transformation of NRK cells.
Masuda A; Takenaga K; Kondoh F; Fukami H; Utsumi K; Okayama H
Oncogene; 1996 May; 12(10):2081-8. PubMed ID: 8668333
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the transformed phenotype of breast cancer by tropomyosin-1.
Mahadev K; Raval G; Bharadwaj S; Willingham MC; Lange EM; Vonderhaar B; Salomon D; Prasad GL
Exp Cell Res; 2002 Sep; 279(1):40-51. PubMed ID: 12213212
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
10. RalA mediates v-Src, v-Ras, and v-Raf regulation of CD44 and fibronectin expression in NIH3T3 fibroblasts.
Ladeda V; Frankel P; Feig LA; Foster DA; Bal de Kier Joffe E; Aguirre-Ghiso JA
Biochem Biophys Res Commun; 2001 May; 283(4):854-61. PubMed ID: 11350063
[TBL] [Abstract][Full Text] [Related]
11. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
Tokumitsu Y; Nakano S; Ueno H; Niho Y
J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
[TBL] [Abstract][Full Text] [Related]
12. KLF8 transcription factor participates in oncogenic transformation.
Wang X; Zhao J
Oncogene; 2007 Jan; 26(3):456-61. PubMed ID: 16832343
[TBL] [Abstract][Full Text] [Related]
13. Stable expression of intracellular Notch suppresses v-Src-induced transformation in avian neural cells.
Mateos S; Amarir S; Laugier D; Marx M; Calothy G
Oncogene; 2007 May; 26(23):3338-51. PubMed ID: 17146440
[TBL] [Abstract][Full Text] [Related]
14. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
15. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.
Sinibaldi D; Wharton W; Turkson J; Bowman T; Pledger WJ; Jove R
Oncogene; 2000 Nov; 19(48):5419-27. PubMed ID: 11114718
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase D2 stimulates cell protrusion in v-Src-transformed cells.
Shen Y; Zheng Y; Foster DA
Biochem Biophys Res Commun; 2002 Apr; 293(1):201-6. PubMed ID: 12054584
[TBL] [Abstract][Full Text] [Related]
17. Amino terminal, but not the carboxy terminal, sequences of tropomyosin-1 are essential for the induction of stress fiber assembly in neoplastic cells.
Bharadwaj S; Shah V; Tariq F; Damartoski B; Prasad GL
Cancer Lett; 2005 Nov; 229(2):253-60. PubMed ID: 16122869
[TBL] [Abstract][Full Text] [Related]
18. v-Src accelerates spontaneous motility via phosphoinositide 3-kinase, phospholipase C and phospholipase D, but abrogates chemotaxis in Rat-1 and MDCK cells.
Platek A; Mettlen M; Camby I; Kiss R; Amyere M; Courtoy PJ
J Cell Sci; 2004 Sep; 117(Pt 20):4849-61. PubMed ID: 15340010
[TBL] [Abstract][Full Text] [Related]
19. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies.
He H; Hirokawa Y; Levitzki A; Maruta H
Cancer J; 2000; 6(4):243-8. PubMed ID: 11038144
[TBL] [Abstract][Full Text] [Related]
20. The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation.
Fan H; Villegas C; Huang A; Wright JA
Cancer Res; 1998 Apr; 58(8):1650-3. PubMed ID: 9563477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
